HVEM/HEK293 HVEM/HEK293 HVEM/HEK293
I. Background | |
皰疹病毒進(jìn)入介質(zhì)(HVEM),,也稱為腫瘤壞死因子受體超家族成員 14 (TNFRSF14),,是 TNF 受體(腫瘤壞死因子)超家族的人細(xì)胞表面受體,。HVEM 在多種 免疫細(xì)胞中表達(dá),,包括 T 細(xì)胞、B 細(xì)胞,、自然殺傷細(xì)胞,、樹突狀細(xì)胞和內(nèi)皮細(xì)胞。它還通 過在黑色素瘤細(xì)胞上的頻繁表達(dá)參與腫瘤的免疫逃避,。 HVEM 有四種不同的配體,,TNFSF14、LTA,、BTLA 和 CD160,,在信號(hào)傳輸中起關(guān)鍵 作用。HVEM 作為一個(gè)分子開關(guān),,可以通過激活轉(zhuǎn)錄因子 NF-kB 與自身的 LIGHT 家族相 互作用,增加炎癥反應(yīng),增強(qiáng)免疫反應(yīng),。它能夠通過它們的死亡結(jié)構(gòu)域或 TRAF 介質(zhì)誘導(dǎo) 信號(hào)級(jí)聯(lián),,激活細(xì)胞存活或凋亡。 | |
II. Description | |
HVEM HEK293 細(xì)胞在 HEK293 細(xì)胞的基礎(chǔ)上,,穩(wěn)定表達(dá)人 HVEM,。 | |
III. Introduction | |
Host Cell: | HEK293 |
Expressed gene: | HVEM |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Synonym(s): | Immunotherapy, CD270, Herpesvirus entry mediator, HVEM, HEK293, HVEM - HEK293, TNFRSF14, BTLA |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | DMEM+10%FBS+1μg/ml puromycin |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen. |
Application(s): | Binding Assay,FACS |
IV. Description of Host Cell Line | |
Organism: | Homo sapiens,human |
Tissue: | Embryonic kidney |
Disease: | Normal |
Morphology: | Epitheloid cell |
Growth Properties: | Adherent |
Ⅴ. Representative Data | |
Figure 1.Recombinant HEK293 stably expressing human HVEM. |